Isramco After 2025: How Much Of The Distribution Story Is True Free Cash And How Much Is Funding
The main article already showed that more Tamar capacity does not automatically mean more cash. This follow-up isolates the cash bridge and shows that 2025 operating cash almost covered distributions, interest and reported investment, but the full cash bridge still had a roughly $185 million gap before Series D and the bank draw.
The main article already made the first point: extra Tamar capacity does not automatically become extra cash at Isramco. This follow-up isolates only the cash layer: how much of the 2025 distribution story really came from free cash, and how much depended on the bond market and the bank line staying open.
That distinction matters because Isramco can produce two different readings, and both are only partly true. On the narrow bridge, the one that looks only at recurring cash generation, 2025 nearly funded itself. The partnership generated $229 million from operating activity and another roughly $5 million from other sources, while paying $13 million of interest, distributing $130 million to unitholders, and investing $39 million in oil and gas assets plus another $51 million in pipeline infrastructure. On that bridge, the year was basically flat, roughly a $1 million surplus. That is why it would be wrong to call the distributions fictional.
But that is not the right bridge if the question is how much cash was actually left for unitholders after the year's real uses of cash. On the full bridge, the relevant all-in cash flexibility view, the partnership also had to absorb $113 million of bond repayments and $73 million that went into deposits and restricted deposits. On that basis, 2025 did not end with a surplus. It opened a roughly $185 million gap before new financing. That hole was closed mainly by the new Series D bond issue, which brought in about $124.7 million net, and by another $40 million draw under the bank facility. Even after those two sources, cash and cash equivalents still fell by $20 million.
That is the thesis. Isramco's 2025 distributions were not funded one-for-one by debt, but they were not clean free cash either. They sat on a mix of healthy operating cash flow, refinancing, an additional bank draw, and a shift of liquidity into layers that are not the same as cash and cash equivalents.
Two Bridges, Two Answers
| Bridge | What it asks | What goes into the 2025 calculation | Result |
|---|---|---|---|
| Narrow cash-generation bridge | Did the operating business almost fund distributions, interest and annual investment on its own | $229 million of operating cash flow plus $5 million of other sources, less $13 million of interest, $130 million of distributions, $39 million of oil and gas investment and $51 million of pipeline investment | Roughly balanced, about a $1 million surplus |
| All-in cash flexibility | How much was really left after the year's actual uses of cash | The same base, but also less $113 million of bond repayments and less $73 million of deposits and restricted deposits | Roughly a $185 million deficit before new financing |
| After new financing | How the year actually closed | Plus $124.7 million net from Series D and another $40 million bank draw | A $20 million decline in cash and cash equivalents |
This is not a technical nicety. It decides whether 2025 should be read as a harvest year or a bridge year. On the narrow bridge, the business still produced enough cash to almost cover distributions, interest and reported investment. On the full bridge, which is the right test for capital flexibility at the unitholder level, 2025 still depended on access to financing.
The liquidity headline looked better than the actual cash position
Anyone who stops at the balance-sheet headline can come away with a more comfortable picture than the cash position really supports. The presentation shows gross debt of about $441 million as of December 31, 2025, against about $111 million of cash, securities and deposits, which leaves net financial debt of about $330 million. That arithmetic is correct, but it does not tell the reader where the liquidity actually sat at year-end, or how much of it was no longer sitting in cash and cash equivalents.
On the balance sheet itself, cash and cash equivalents fell to just $29.6 million, down from $51.0 million at the end of 2024. At the same time, the partnership was holding $77.5 million of short-term deposits, $3.5 million of marketable securities and another $4.5 million of restricted short-term deposits. In other words, the liquidity layer did not disappear, but a large part of it was no longer sitting in the most immediately available cash bucket.
That also explains why two apparently contradictory things happened at the same time. On the one hand, current assets increased and working capital swung from a $45 million deficit at the end of 2024 to a $27 million surplus at the end of 2025, and the report explicitly ties that improvement mainly to the Series D bond issue. On the other hand, cash and cash equivalents themselves still fell by $20 million. Put differently, the balance sheet got more comfortable mainly because of financing, not because 2025 threw off excess cash for unitholders.
There is an important nuance here. Not every deposit is lost cash. Some of it is ordinary liquidity management, and in January 2026 the partnership even released a roughly $4.5 million restricted deposit that had been posted against a Natgaz guarantee. But that does not change the main picture: when cash and cash equivalents fall to $29.6 million, the wider $111 million liquidity stack cannot be treated as if it were one identical pool of free cash.
The funding stack remained part of the story, even without covenant stress
The lazy reading would be to say that if Isramco extended a bank line and issued a new bond series, it must have been moving toward financial stress. That is the wrong read. The covenants were still very far from the edge. Economic equity stood at $2.064 billion at year-end against a $675 million minimum, and net financial debt was about $330 million against EBITDA of about $334 million, or roughly 99%, far below the 400% ceiling for Series D and the 450% ceiling for Series B and C. Reported LTV also remained very low at 12% and 18% for Series B and C.
That is exactly why the funding layer is more interesting as a structural choice than as a distress signal. In September 2025, Isramco raised about $124.7 million net through Series D, with a 5.01% annual coupon and no principal amortization until January 2031, with final repayment only in July 2035. In parallel, the bank loan reached $110 million by year-end 2025, after a second $40 million draw in June 2025 at a fixed 5.87% rate. Then, in January 2026, the partnership made sure that the still-unused $40 million balance of the facility was extended through January 10, 2027, with any future use becoming a loan for up to seven years from the draw date.
The message is clear: even without covenant pressure, management chose to keep another layer of flexibility alive. That is not unusual when a partnership is carrying an expansion project, export-system upgrades and continued development work. But it does mean that the 2025 distributions rested on an active funding architecture, not only on cash that simply dropped out of Tamar.
This now has to be tested against the next Tamar spending cycle, not just against 2025
The key issue for unitholders is not whether 2025 was a good year or a bad one. It is what kind of year it was. The right read for now is a bridge year. By the end of 2025, the partnership had already invested about $181 million in its share of stage one of the expansion project, about $38 million in the export-system upgrade outside Israel and another $46 million in the Nitzana project. On top of that, in December 2025 the Tamar partners took a final investment decision on two new development wells with a total budget of about $466.5 million, of which Isramco's share is estimated at about $134 million.
That is where true free cash now gets tested. If more capacity, more export availability and the next development leg start turning into higher operating cash in 2026 and 2027, then 2025 can later be read as a year in which the partnership opened temporary financing against a heavy investment cycle. But if operating cash does not rise quickly enough, the distributions will look less like the harvest of a mature asset and more like a policy that still leans on the debt market and the bank line.
That chart does not say debt is out of control. It says something sharper: even in years of strong operating cash flow, and even after operating expansion, Isramco still has not shown a consistent decline in net debt alongside rising distributions. So the real question is no longer whether the asset can produce cash. It is how much of that cash is actually available to unitholders after every other layer has taken its share.
Bottom Line
2025 does not break Isramco's distribution thesis, but it does put a clear boundary around it. Operating cash flow was strong enough that on the narrow bridge it almost funded interest, distributions and annual investment. The problem is that unitholders do not live on the narrow bridge. They live on the cash that remains after debt amortization, after deposits, after projects, and after the decision to keep another $40 million of bank capacity open through 2027.
So the cleaner way to read Isramco's post-2025 distributions is this: not fully debt-funded, but not purely free-cash funded either. They were supported by a business that still throws off substantial operating cash, while also leaning on a funding system that remained active in order to bridge the period between heavy investment and the point when the expansion is supposed to start paying back.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.